UNSPSC 51101902: Mefloquine

This classification denotes an antimalarial agent with the molecular formula C17H16F6N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TML814419R, chemically known as 4-quinolinemethanol, .alpha.-2-piperidinyl-2,8-bis(trifluoromethyl)-, (r*,s*)-(.+/-.)- but generally known as mefloquine, which bears US NIH Compound Identifier 4046. European Medicines Agency schedules Mefloquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08709MIG.

UNSPSC 51101902 Mefloquine (Commodity) covers antimalarial pharmaceutical products procured by state and local health departments and county agencies, though the recent opportunities block shows minimal activity directly aligned with this code's narrow commodity scope. State and local governments acquire mefloquine and related pharmaceutical inventory through piggyback contracts with established cooperative purchasing consortiums — notably the MMCAP Infuse vehicle — to support emergency preparedness, disease prevention, and public health stockpiling. The Illinois Department of Public Health and Seminole County, Florida represent the kinds of issuing bodies active in pharmaceutical procurement under related codes, though recent posted opportunities do not show explicit mefloquine solicitations; instead, they feature antimalarial and emergency-response pharmaceuticals (Doxycycline, Ciprofloxacin, and Naloxone) awarded through IFB and piggyback mechanisms.

Recent activity centers in Illinois and Florida, with procurement driven by state health departments and county public health agencies using cooperative purchasing vehicles to aggregate volume and reduce unit costs. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract to Chartwell Rx LLC on August 28, 2026 (solicitation 26482DPHPREPDB53392, IFB, closed) for pharmaceutical warehouse supply of antimicrobial tablets over a three-year term. Seminole County, Florida posted an IFB (60459723LAS) on June 30, 2026 (response deadline July 26, 2023) seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through quarterly deliveries. The code itself shows limited recent direct solicitation; vendors pursuing state and local pharmaceutical procurement should monitor cooperative purchasing consortiums and county health department RFQs for mefloquine and related antimalarial inventory needs.